A Systematic Review Concerning the Relation between the Sympathetic Nervous System and Heart Failure with Preserved Left Ventricular Ejection Fraction
暂无分享,去创建一个
W. Verloop | M. Voskuil | M. Bots | P. Blankestijn | P. Doevendans | M. Cramer | B. Santema | Martine M. A. Beeftink
[1] H. Verberne,et al. For what endpoint does myocardial 123I-MIBG scintigraphy have the greatest prognostic value in patients with chronic heart failure? Results of a pooled individual patient data meta-analysis. , 2014, European heart journal cardiovascular Imaging.
[2] A. de la Sierra,et al. Heart rate and heart rate variability in resistant versus controlled hypertension and in true versus white-coat resistance , 2014, Journal of Human Hypertension.
[3] T. Yonezawa,et al. Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats , 2014, Cardiovascular Diabetology.
[4] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[5] W. Paulus,et al. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. , 2013, Journal of the American College of Cardiology.
[6] T. Nakata,et al. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. , 2013, JACC. Cardiovascular imaging.
[7] L. Bortolotto,et al. High muscle sympathetic nerve activity is associated with left ventricular dysfunction in treated hypertensive patients. , 2013, American journal of hypertension.
[8] W. Verloop,et al. Ischemia and Reactive Oxygen Species in Sympathetic Hyperactivity States: A Vicious Cycle that can be Interrupted by Renal Denervation? , 2013, Current Hypertension Reports.
[9] R. Wachter,et al. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. , 2013, JAMA.
[10] F. Kajiya,et al. Increased passive stiffness of cardiomyocytes in the transverse direction and residual actin and myosin cross-bridge formation in hypertrophied rat hearts induced by chronic β-adrenergic stimulation. , 2013, Circulation journal : official journal of the Japanese Circulation Society.
[11] E. Vink,et al. Sympathetic Hyperactivity in Chronic Kidney Disease: Pathophysiology and (New) Treatment Options , 2013, Current Hypertension Reports.
[12] Biykem Bozkurt,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.
[13] 吉川 和歌子,et al. Increased passive stiffness of cardiomyocytes in the transverse direction and residual actin and myosin cross-bridge formation in hypertrophied rat hearts induced by chronic β-adrenergic stimulation , 2013 .
[14] N. de Las Heras,et al. Spironolactone prevents alterations associated with cardiac hypertrophy produced by isoproterenol in rats: involvement of serum‐ and glucocorticoid‐regulated kinase type 1 , 2012, Experimental physiology.
[15] M. Böhm,et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. , 2012, Journal of the American College of Cardiology.
[16] P. Vardas,et al. Effects of the long‐term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study , 2012, European journal of heart failure.
[17] M. Frenneaux,et al. Epidemiology and diagnosis of heart failure with preserved left ventricular ejection fraction: rationale and design of the study , 2012, European journal of heart failure.
[18] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.
[19] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[20] A. Riolobos,et al. Increased oxidative stress, the renin-angiotensin system, and sympathetic overactivation induce hypertension in kidney androgen-regulated protein transgenic mice. , 2011, Free radical biology & medicine.
[21] F. Cacciapuoti. Molecular mechanisms of left ventricular hypertrophy (LVH) in systemic hypertension (SH)-possible therapeutic perspectives. , 2011, Journal of the American Society of Hypertension : JASH.
[22] S. Fröhling,et al. Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. , 2011, Journal of the American College of Cardiology.
[23] Q. Shen,et al. Distinct actions of intermittent and sustained β-adrenoceptor stimulation on cardiac remodeling , 2011, Science China Life Sciences.
[24] B. Borlaug,et al. Diastolic and Systolic Heart Failure Are Distinct Phenotypes Within the Heart Failure Spectrum , 2011, Circulation.
[25] W. Paulus,et al. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. , 2011, European heart journal.
[26] S. Malpas. Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. , 2010, Physiological Reviews.
[27] Akshay S. Desai,et al. The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis. , 2010, Journal of cardiac failure.
[28] J. S. Janicki,et al. Sympathetic Nervous System Modulation of Inflammation and Remodeling in the Hypertensive Heart , 2010, Hypertension.
[29] J. Bronzwaer,et al. Diastolic and systolic heart failure: Different stages or distinct phenotypes of the heart failure syndrome? , 2009, Current heart failure reports.
[30] J. Ioannidis,et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. , 2009, Journal of clinical epidemiology.
[31] R. Wachter,et al. Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure , 2009, European heart journal.
[32] C. H. Conrad,et al. Isoproterenol-induced myocardial injury and diastolic dysfunction in mice: structural and functional correlates. , 2009, Comparative medicine.
[33] J. Ioannidis,et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].
[34] A. Cohen-Solal,et al. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). , 2009, Journal of the American College of Cardiology.
[35] D. Kitzman,et al. Effect of aldosterone antagonism on exercise tolerance, Doppler diastolic function, and quality of life in older women with diastolic heart failure. , 2009, Congestive heart failure.
[36] G. Mancia,et al. Sympathetic and Baroreflex Cardiovascular Control in Hypertension-Related Left Ventricular Dysfunction , 2009, Hypertension.
[37] C. Rosendorff. The chicken and the egg: sympathetic nervous system activity and left ventricular diastolic dysfunction. , 2009, Hypertension.
[38] W. Young,et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. , 2008, The Journal of clinical endocrinology and metabolism.
[39] J. Wess,et al. Deficiency of M2 muscarinic acetylcholine receptors increases susceptibility of ventricular function to chronic adrenergic stress. , 2008, American journal of physiology. Heart and circulatory physiology.
[40] S. Mizutani,et al. Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies , 2008, Heart Failure Reviews.
[41] K. Dickstein,et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. , 2007, European heart journal.
[42] A. Hoes,et al. Clinical epidemiology of heart failure , 2007, Heart.
[43] Mahipal Singh,et al. &bgr;1 Integrins Modulate &bgr;-Adrenergic Receptor–Stimulated Cardiac Myocyte Apoptosis and Myocardial Remodeling , 2007, Hypertension.
[44] T. Takano,et al. Relationship between plasma norepinephrine at peak exercise and 123I-MIBG imaging of the heart and lower limbs in heart failure. , 2007, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.
[45] R. McKelvie,et al. Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES. , 2007, Journal of the American College of Cardiology.
[46] M. Lohse,et al. Interstitial remodeling in β1-adrenergic receptor transgenic mice , 2006, Basic Research in Cardiology.
[47] D. Kass,et al. Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients With Heart Failure and a Preserved Ejection Fraction , 2006, Circulation.
[48] T. Fukutomi,et al. The relationship between variables of 123-I-metaiodobenzylguanidine cardiac imaging and clinical status of the patients with diastolic heart failure. , 2006, International journal of cardiology.
[49] G. Germanó,et al. Autonomic cardiovascular control and diastolic dysfunction in hypertensive subjects. , 2006, International journal of cardiology.
[50] H. Katus,et al. Spironolactone preserves cardiac norepinephrine reuptake in salt-sensitive Dahl rats. , 2006, Endocrinology.
[51] A. Leite-Moreira,et al. Current perspectives in diastolic dysfunction and diastolic heart failure , 2006, Heart.
[52] Matthias Dütsch,et al. Quantitative studies of autonomic function , 2006, Muscle & nerve.
[53] A. Hoes,et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.
[54] J. McMurray,et al. Neurohumoral pathways in heart failure with preserved systolic function. , 2005, Progress in cardiovascular diseases.
[55] T. Iwasaka,et al. Iodine 123‐metaiodobenzylguanidine imaging reflect generalized sympathetic activation in patients with left ventricular dysfunction , 2005, Clinical physiology and functional imaging.
[56] B. Wallin,et al. Long-term variability and reproducibility of resting human muscle nerve sympathetic activity at rest, as reassessed after a decade , 1993, Clinical Autonomic Research.
[57] W. Gaasch,et al. Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle. , 2004, The New England journal of medicine.
[58] S. Jackson. Diastolic heart failure , 2004, BMJ : British Medical Journal.
[59] T. LeJemtel,et al. Heart Rate Variability and Diastolic Heart Failure , 2004, Pacing and clinical electrophysiology : PACE.
[60] Karl Swedberg,et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.
[61] Jeffrey C. Hill,et al. Usefulness of clinical variables, echocardiography, and levels of brain natriuretic peptide and norepinephrine to distinguish systolic and diastolic causes of acute heart failure. , 2003, The American journal of cardiology.
[62] M. Zile. Heart failure with preserved ejection fraction: is this diastolic heart failure? , 2003, Journal of the American College of Cardiology.
[63] P. Blankestijn,et al. Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure. , 2003, Journal of the American Society of Nephrology : JASN.
[64] J. Kooner,et al. Myocardial beta-adrenoceptor density one month after acute myocardial infarction predicts left ventricular volumes at six months. , 2002, Journal of the American College of Cardiology.
[65] P. Doevendans,et al. Diagnosing diastolic heart failure , 2002, European journal of heart failure.
[66] D. Brutsaert,et al. New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. , 2002, Circulation.
[67] A. Iskandrian,et al. MIBG imaging , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[68] I. Kubota,et al. Left ventricular diastolic dysfunction in patients with bronchial asthma with long-term oral β2-adrenoceptor agonists , 2001 .
[69] I. Kubota,et al. Left ventricular diastolic dysfunction in patients with bronchial asthma with long-term oral beta2-adrenoceptor agonists. , 2001, American heart journal.
[70] P. Blankestijn,et al. ENALAPRIL AND LOSARTAN ARE EQUALLY EFFECTIVE IN REDUCING SYMPATHETIC HYPERACTIVITY IN CHRONIC RENAL FAILURE: P2.3 , 2000 .
[71] B. Chandrasekar,et al. Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression. , 2000, Circulation.
[72] H. Schunkert,et al. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. , 1998, Cardiovascular research.
[73] U. Nixdorff,et al. Beta-adrenergic stimulation enhances left ventricular diastolic performance in normal subjects. , 1997, Journal of cardiovascular pharmacology.
[74] B. Strauer,et al. Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients , 1996, Journal of hypertension.
[75] A. Quyyumi,et al. Cardiac sympathetic nerve function in congestive heart failure. , 1996, Circulation.
[76] K J Osterziel,et al. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. , 1996, Circulation.
[77] G. Grassi,et al. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. , 1995, Circulation.
[78] I. Meredith,et al. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. , 1990, Physiological reviews.
[79] A. Marmor,et al. A single dose of cilazapril improves diastolic function in hypertensive patients. , 1989, The American journal of medicine.
[80] K. White,et al. Clinical epidemiology. , 1983, International journal of epidemiology.